Fingerprint
Dive into the research topics of 'Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction
Tamás Radovits, Leila Seres, Domokos Gero, Irina Berger, Csaba Szabó, Matthias Karck, Gábor Szabó
Research output: Contribution to journal › Article › peer-review
38
Scopus
citations